ABIO Annual ROA
-14.10%
+8.94%+38.80%
31 December 2023
Summary:
As of February 5, 2025, ABIO annual return on assets is -14.10%, with the most recent change of +8.94% (+38.80%) on December 31, 2023. During the last 3 years, it has risen by +5.21% (+26.98%).ABIO ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABIO Quarterly ROA
-19.51%
-4.00%-25.79%
30 June 2024
Summary:
As of February 5, 2025, ABIO quarterly return on assets is -19.51%, with the most recent change of -4.00% (-25.79%) on June 30, 2024. Over the past year, it has dropped by -6.18% (-46.36%).ABIO Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABIO ROA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +38.8% | -46.4% |
3 y3 years | +27.0% | +36.3% |
5 y5 years | +87.9% | +36.3% |
ABIO ROA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | +74.9% | -224.0% |
ARCA Biopharma ROA History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | -19.51%(+25.8%) |
Mar 2024 | - | -15.51%(+16.4%) |
Dec 2023 | -14.10%(-38.8%) | -13.33%(+1.6%) |
Sept 2023 | - | -13.12%(-11.4%) |
June 2023 | - | -14.80%(-17.6%) |
Mar 2023 | - | -17.96%(-15.3%) |
Dec 2022 | -23.04%(-34.5%) | -21.21%(-26.9%) |
Sept 2022 | - | -29.00%(-7.6%) |
June 2022 | - | -31.38%(-1.8%) |
Mar 2022 | - | -31.96%(+3.2%) |
Dec 2021 | -35.18%(+82.2%) | -30.96%(+1.1%) |
Sept 2021 | - | -30.63%(+13.0%) |
June 2021 | - | -27.10%(-0.8%) |
Mar 2021 | - | -27.33%(-14.8%) |
Dec 2020 | -19.31%(-69.9%) | -32.06%(+9.3%) |
Sept 2020 | - | -29.34%(-44.9%) |
June 2020 | - | -53.26%(-5.8%) |
Mar 2020 | - | -56.56%(-3.3%) |
Dec 2019 | -64.22%(-44.7%) | -58.51%(-8.9%) |
Sept 2019 | - | -64.25%(-11.0%) |
June 2019 | - | -72.17%(-10.7%) |
Mar 2019 | - | -80.86%(-2.8%) |
Dec 2018 | -116.21%(-22.2%) | -83.21%(-14.6%) |
Sept 2018 | - | -97.45%(-5.7%) |
June 2018 | - | -103.38%(-9.1%) |
Mar 2018 | - | -113.71%(+3.4%) |
Dec 2017 | -149.40%(+123.5%) | -110.01%(+17.9%) |
Sept 2017 | - | -93.33%(+13.3%) |
June 2017 | - | -82.38%(+27.9%) |
Mar 2017 | - | -64.39%(+20.2%) |
Dec 2016 | -66.84%(+131.1%) | -53.59%(+20.1%) |
Sept 2016 | - | -44.62%(+25.1%) |
June 2016 | - | -35.66%(+18.5%) |
Mar 2016 | - | -30.10%(-7.7%) |
Dec 2015 | -28.92%(-51.8%) | -32.62%(-12.4%) |
Sept 2015 | - | -37.25%(-16.8%) |
June 2015 | - | -44.77%(-24.3%) |
Mar 2015 | - | -59.11%(+18.0%) |
Dec 2014 | -60.06%(+47.9%) | -50.09%(-2.2%) |
Sept 2014 | - | -51.20%(+7.4%) |
June 2014 | - | -47.66%(+15.0%) |
Mar 2014 | - | -41.46%(-8.7%) |
Dec 2013 | -40.62%(-69.8%) | -45.39%(+11.0%) |
Sept 2013 | - | -40.90%(-20.0%) |
June 2013 | - | -51.11%(-53.1%) |
Mar 2013 | - | -108.93%(-2.6%) |
Dec 2012 | -134.50%(+63.0%) | -111.86%(+2.5%) |
Sept 2012 | - | -109.08%(-1.1%) |
June 2012 | - | -110.32%(+60.3%) |
Mar 2012 | - | -68.80%(-10.5%) |
Dec 2011 | -82.50%(-20.1%) | -76.83%(+6.6%) |
Sept 2011 | - | -72.06%(+4.6%) |
June 2011 | - | -68.92%(-24.8%) |
Mar 2011 | - | -91.64%(+16.3%) |
Dec 2010 | -103.24% | -78.78%(-33.4%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2010 | - | -118.37%(+3.4%) |
June 2010 | - | -114.50%(+8.1%) |
Mar 2010 | - | -105.91%(+246.6%) |
Dec 2009 | -97.50%(-44.4%) | -30.56%(-294.2%) |
Sept 2009 | - | 15.74%(+1139.4%) |
June 2009 | - | 1.27%(-86.2%) |
Mar 2009 | - | 9.19%(-131.6%) |
Dec 2008 | -175.39%(+2076.1%) | -29.11%(-28.5%) |
Sept 2008 | - | -40.72%(+1.3%) |
June 2008 | - | -40.20%(+252.6%) |
Mar 2008 | - | -11.40%(+39.7%) |
Dec 2007 | -8.06%(-91.0%) | -8.16%(-79.1%) |
Sept 2007 | - | -39.03%(-6.2%) |
June 2007 | - | -41.59%(-31.8%) |
Mar 2007 | - | -61.00%(-8.0%) |
Dec 2006 | -89.28%(+16.8%) | -66.34%(+39.6%) |
Sept 2006 | - | -47.53%(-0.3%) |
June 2006 | - | -47.65%(-9.6%) |
Mar 2006 | - | -52.72%(-17.9%) |
Dec 2005 | -76.46%(-0.2%) | -64.20%(+11.9%) |
Sept 2005 | - | -57.37%(+12.8%) |
June 2005 | - | -50.85%(+11.4%) |
Mar 2005 | - | -45.64%(-19.0%) |
Dec 2004 | -76.59%(-35.2%) | -56.36%(-0.8%) |
Sept 2004 | - | -56.83%(-12.0%) |
June 2004 | - | -64.58%(-19.2%) |
Mar 2004 | - | -79.97%(-21.4%) |
Dec 2003 | -118.25%(-12.0%) | -101.69%(-21.5%) |
Sept 2003 | - | -129.60%(+16.0%) |
June 2003 | - | -111.73%(+11.4%) |
Mar 2003 | - | -100.27%(-24.9%) |
Dec 2002 | -134.31%(+12.7%) | -133.57%(+21.5%) |
Sept 2002 | - | -109.94%(-19.3%) |
June 2002 | - | -136.23%(-1.4%) |
Mar 2002 | - | -138.22%(+25.2%) |
Dec 2001 | -119.21%(+78.6%) | -110.36%(+8.6%) |
Sept 2001 | - | -101.59%(+21.5%) |
June 2001 | - | -83.63%(+25.9%) |
Mar 2001 | - | -66.44%(+7.4%) |
Dec 2000 | -66.74%(+86.3%) | -61.85%(+22.6%) |
Sept 2000 | - | -50.46%(+7.0%) |
June 2000 | - | -47.16%(+9.8%) |
Mar 2000 | - | -42.96%(+16.0%) |
Dec 1999 | -35.82%(+36.4%) | -37.04%(+8.4%) |
Sept 1999 | - | -34.17%(-0.4%) |
June 1999 | - | -34.31%(+9.7%) |
Mar 1999 | - | -31.29%(+17.1%) |
Dec 1998 | -26.26%(+54.3%) | -26.73%(+25.0%) |
Sept 1998 | - | -21.39%(+23.4%) |
June 1998 | - | -17.34%(+8.7%) |
Mar 1998 | - | -15.95%(+0.5%) |
Dec 1997 | -17.02%(-66.7%) | -15.87%(+1.8%) |
Sept 1997 | - | -15.59%(-40.2%) |
June 1997 | - | -26.09%(+3.0%) |
Mar 1997 | - | -25.33% |
Dec 1996 | -51.06% | - |
FAQ
- What is ARCA biopharma annual return on assets?
- What is the all time high annual ROA for ARCA biopharma?
- What is ARCA biopharma annual ROA year-on-year change?
- What is ARCA biopharma quarterly return on assets?
- What is the all time high quarterly ROA for ARCA biopharma?
- What is ARCA biopharma quarterly ROA year-on-year change?
What is ARCA biopharma annual return on assets?
The current annual ROA of ABIO is -14.10%
What is the all time high annual ROA for ARCA biopharma?
ARCA biopharma all-time high annual return on assets is -8.06%
What is ARCA biopharma annual ROA year-on-year change?
Over the past year, ABIO annual return on assets has changed by +8.94% (+38.80%)
What is ARCA biopharma quarterly return on assets?
The current quarterly ROA of ABIO is -19.51%
What is the all time high quarterly ROA for ARCA biopharma?
ARCA biopharma all-time high quarterly return on assets is 15.74%
What is ARCA biopharma quarterly ROA year-on-year change?
Over the past year, ABIO quarterly return on assets has changed by -6.18% (-46.36%)